Valneva SE ADR
Price & Volume
Stats
See moreOpen | $11.79 |
Previous Close | $11.99 |
Day Range | $11.74-$11.79 |
52W Range | $5.42-$12.25 |
Market Cap | $993.8M |
Shares Short | 142,590 |
Financials
See moreRevenue (12 Mos) | $179.9M |
Revenue Growth (YoY) | -35.8% |
Gross Profit (12 Mos) | -$3.6M |
Diluted EPS | -$1.54 |
News
See moreYahoo Finance • 3 months ago
Valneva to Further Consolidate its Operations in France
Yahoo Finance • 3 months ago
Valneva va consolider ses activités en France
Yahoo Finance • 3 months ago
Valneva Announces Positive Final Phase 2 Results for Lyme Disease Vaccine Candidate
Yahoo Finance • 3 months ago
Valneva annonce des résultats finaux positifs de Phase 2 pour son candidat vaccin contre la maladie de Lyme
About
CEO | Mr. Thomas Lingelbach |
Address | 6 rue Alain Bombard, Saint-Herblain, France, 44800 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 713 |
